Jun 6, 20233 minANNOUNCEMENTSMEDSIR Study Finds No Progression-Free Survival Benefit with Palbociclib Maintenance After First-Lin
Oct 31, 20222 minCANCER RESEARCHSafety Analysis of PARSIFAL Trial Published in The Oncologist Journal
Oct 7, 20212 minANNOUNCEMENTSPARSIFAL: Identifying an endocrine agent for palbociclib in endocrine sensitive ABC